International Clinical Trials |
 |
|
|
|
|
 |
| |
|
|
|
|
The Great Data Protection Regulation
Protected and Prepared
To protect personal data, the industry must adapt to a new set of practices implemented by the Great Protection Regulation, as explained Mike Novotny and Nick O’Brien at Medrio.
|
|
|
Risk Management Methods
Preventable Problems
Sudeep Pattnaik at ThoughtSphere examines risk-based monitoring methods, suggesting that they are becoming the newly recognised industry standard.
|
|
|
|
Central Nervous System Trials
Clinical Complexities
Clinical trials for the central nervous system are becoming more intricate and expensive. Tom Zoda at Syneos Health discusses the challenges that must be overcome in this sector.
|
|
|
Patient Engagement and Compliance
Perfect Platform
Following the guidelines set out by the Washington University DIAN-TU platform, Graham Wylie at MRN states that these standards are good for current practices, noting the ways it affects Alzheimer’s research.
|
|
|
CNS Drug Development
Clinical Acceleration
Dr Kemi Olugemo at PAREXEL highlights how the need for an increase in clinical trials is vital as diseases caused by the central nervous system accelerate.
|
|
|
Clinical Reference Models
Bridging the Divide
Using electronic document management and trial master file reference models can offer assistance when managing the growing amount of regulatory
submissions, explains Patricia Santos-Serrao at MasterControl.
|
|
|
|
Digitising Patient-Reported Outcomes
PROMs in Practise
By using digital patient-reported outcome measures, healthcare organisations are now able to measure patient outcomes with greater
accuracy. Dr Tim Williams at My Clinical Outcomes details the ways this helps care and practices.
|
|
|
|
Uniting professionals across life sciences, DIA Europe 2018 will be held this year in Basel, Switzerland, on 17-19 April.
|
|
|
|
|
Mitigating Data Risks
Promoting Patterns
Poor data management is negatively affecting adverse event and endpoint adjudication in clinical trials. Abraham Gutman at AG Mednet believes developing and validating control and event patterns may be the solution.
|
|
|
|
|
Patient Retention
Dodging Delays
Martin Collyer at Bioclinica talks about the new methods that must be taken to reduce patient-loss during the follow-up period.
|
|
|
Behavioural Economics
Assessing Attitudes
Creating and maintaining patient engagement has been researched in numerous ways. One of those approaches is Behaviour Economics, which Keith Meadows at DHP Research & Consultancy explores.
|
|
|
Patient Participation
Changing Ways
Kurt Mussina at Frenova Renal Research points out that recruitment rates can be improved through patient-centricity, thereby minimising administrative and practical difficulties.
|
|
|
Patient Centricity
Promising Participation
Lea Studer at SCORR Marketing examines the role of patient centricity within trials, suggesting that the process could be improved by keeping patients informed, seeking their input, and analysing their desires
|
|
|
Patient-Reported Outcomes
Collective Communication
The collection of patient-reported outcomes in clinical trials has become more commonplace; however, Dr Jenny Retzler at York Health Economics Consortium explores the problems that may be countered though early engagement.
|
|
|
|
|
mHealth Developments
A Valued Perspective
The acceleration of R&D is coming to fruition thanks to the implementation of mHealth technologies. David Blackman at PPD hopes it will improve practices and explore new markets.
|
|
|
|
|
|
